Molecular Docking and Ligand Specificity in Fragment-Based Inhibitor Discovery

Nature Chemical Biology - United Kingdom
doi 10.1038/nchembio.155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fragment-Based Ligand Discovery Meets Phage Display

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2007English

Natural Product–based Fragment Libraries for Ligand Discovery

Science-Business eXchange
2013English

Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2009English

Analysis of Ligand Binding Specificity of Estrogen Receptor by the Fragment Molecular Orbital Method

Journal of Computer Chemistry, Japan
2018English

Fragment-Based Drug Discovery: Concept and Aim

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2010English

Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2008English

Accurate Prediction of Protein-Ligand Binding by Combined Molecular Dynamics-Based Docking and QM/MM Methods

Biophysical Journal
Biophysics
2018English

Integrated Biophysical Approach to Fragment Screening and Validation for Fragment-Based Lead Discovery

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

pKa Based Protonation States and Microspecies for Protein–ligand Docking

Journal of Computer-Aided Molecular Design
Theoretical ChemistryDrug DiscoveryComputer Science ApplicationsPhysical
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy